ReviewTechnology in cancer research & treatment

Prognostic Parameters of Palbociclib in HR+/HER2- Advanced Breast Cancer: A Narrative Review.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.